pellicle
Professional Dingbat, Guru and Merkintologist
I was surprised to get a comment on my blog from a Dr. Didier Lapeyre.
I looked him up and found that he is developing a new mechanical heart valve. I thought some here would be interested in it, particularly because of some of the design objectives.
I looked him up and found that he is developing a new mechanical heart valve. I thought some here would be interested in it, particularly because of some of the design objectives.
refValve design and Lapeyre Industries
Unfortunately, there has been little innovation in valve design in the last thirty years; until now. While the existing market has been dominated by Edward Lifesciences, Medtronic, St. Jude Medical and Sorin, which accounts for 95% of all valves, Dr. Lapeyre and Lapeyre Industries have quietly been working on a new valve to address these problems for over twenty years.
The new design by Lapeyre addresses the problems of both existing mechanical and tissue valves. While made of durable metallic materials, the innovative three leaflet design mimics both native and current tissue valves, resulting in less damage to platelets, less hemolysis or destruction of other blood components leading to a decreased incidence of thrombotic events. This means that patients can have durability without anti-coagulation, a monumental breakthrough for cardiac surgery.
When will this valve be commercially available?
Lapeyre industries has begun limited human trials earlier this year in India and Germany, and anticipates extending these trials to larger number of facilities in Europe by 2014. They hope to make the valve available on a large scale basis, starting in Europe in 2015. Until then, we eagerly await more news of their trials and the future of valve replacement.